Supernus Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
41.50
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.36
|
0.03
|
-0.33
|
-91.67%
|
|
2022-06-30
|
0.29
|
0.56
|
0.27
|
93.10%
|
|
2022-03-31
|
0.24
|
0.04
|
-0.20
|
-83.33%
|
|
2021-12-31
|
0.24
|
0.04
|
-0.20
|
-83.33%
|
|
2021-09-30
|
0.23
|
0.40
|
0.17
|
73.91%
|
|
2021-06-30
|
0.20
|
0.43
|
0.23
|
115.00%
|
|
2021-03-31
|
0.24
|
0.11
|
-0.13
|
-54.17%
|
|
2020-12-31
|
0.52
|
0.57
|
0.05
|
9.62%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.63
|
|
2021-12-31
|
0.98
|
|
2020-12-31
|
2.36
|
|
2019-12-31
|
2.11
|
|
2018-12-31
|
2.06
|
|
2017-12-31
|
1.24
|
|
2016-12-31
|
1.81
|
|
2015-12-31
|
0.27
|
|
2014-12-31
|
0.22
|
|
2013-12-31
|
-2.20
|
|
2012-12-31
|
-2.09
|